As outlined in the previous section, not only does HMGB1 bind platelets via TLR4, it also activates TLR9-dependent pathways in cancer cells, thereby promoting tumor cell proliferation, adhesion, migration and invasion after surgical stress. Here, TLR9 is linked to cancer.